Indian origin scientist’s gene therapy shows promise in slowing AMDApril 30th, 2011 - 5:47 pm ICT by ANI
Washington, April 30 (ANI): A new in vivo study by researchers at Tufts University School of Medicine has found that a gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD).
Led by senior author Rajendra Kumar-Singh, the researchers demonstrated for the first time that CD59 delivered by a gene therapy approach significantly reduced the uncontrolled blood vessel growth and cell death typical of AMD, the most common cause of blindness in the elderly.
Activation of the complement system, a part of the immune system, is responsible for slowly killing cells in the back of the eye, leading to AMD. Activation of this system leads to the generation of pores or holes known as ‘membrane attack complex’ or MAC in cell membranes. CD59 is known to block the formation of MAC.
“CD59 is unstable and hence previous studies using CD59 have had limited success. The gene therapy approach that we developed continuously produces CD59 in the eye and overcomes these barriers, giving us renewed hope that it can be used to fight the progression of AMD and potentially other diseases,” said Kumar-Singh.
The current standard treatment for some forms of AMD requires an injection directly into the eye approximately every four weeks. According to Kumar-Singh, gene therapy approaches to treat AMD are especially attractive because they will allow patients to be treated less frequently, reducing patient discomfort and lowering chances of infection and other side effects associated with frequent injections into the eye.
the treatment of both the dry and wet forms of AMD.
The study has been published in PLoS ONE. (ANI)
- Breakthrough gene therapy could preserve vision - Aug 17, 2010
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Additional genes linked to age-related macular degeneration identified - Apr 13, 2010
- Drugs to treat age-related blindness - Feb 07, 2011
- Drug for bowel cancer can treat eye disease - Jun 14, 2010
- Blinding disease drug shows promise for diabetic retinopathy patients - Apr 28, 2010
- Inexpensive drug to prevent sight loss shown to be safe, effective - Jun 11, 2010
- Promising results of gene therapy to treat eye diseases - Aug 14, 2010
- London hospital to do Europe's first embryonic stem cell trial - Sep 24, 2011
- First clinical trial of gene therapy offers muscular dystrophy clues - Oct 07, 2010
- Novel gene therapy shows promise against Alzheimer's - Mar 05, 2011
- Stem cell therapy could 'help the blind see within 6 weeks' - Nov 22, 2010
- Liver, not brain, may be source of Alzheimer's plaques - Mar 04, 2011
- Prosthetic retina shows promise in restoring sight - May 18, 2012
Tags: age related macular degeneration, amd, blood vessel growth, cause of blindness, cell death, complement system, frequent injections, gene therapy approach, immune system, indian origin, macular degeneration, membrane attack, patient discomfort, plos one, pores, rajendra kumar, school of medicine, tufts university school, tufts university school of medicine, vivo study